VivoSeq
Other

Fibroma

9

Pipeline Programs↗

2

Active Trials↗

7

Companies Involved↗

Fibroma is an early-stage landscape with 9 programs across 7 companies. The most active players are AbbVie, Eastern Cooperative Oncology Group, Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA). 1 therapy is approved.

Intelligence

Pipeline Metrics

Competitive Density

36/100

Pipeline Velocity

6/100

Mech. Concentration

33/100

Completion Rate

100/100

Attrition Rate

0/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

AbbVie logo

AbbVie

1 program

Phase 1E

Eastern Cooperative Oncology Group

1 program

Phase 2C

Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)

1 program

Phase 2C

Cerimon Pharmaceuticals

1 program

Phase 2E

Esteve Pharmaceuticals, S.A.

1 program

Phase 2Merck & Co. logo

Merck & Co.

1 program

Phase 2

Pipeline

Programs by Phase

Analysis

Trial Status

6

clinical trials

Completed4 · 67%
Recruiting1 · 17%
Enrolling by invitation1 · 17%

Clinical Trials

Trial Activity

6 trials

Feasibility and Tolerability of IMLYGIC for the Treatment of Cutaneous Neurofibromas in Adults With NF1
Recruiting·JJohns Hopkins University·Phase 1·NCT07102394·10 enrolled
Assessing the Efficacy of Repeat, Monthly Treatments of Deoxycholate for NF1 Associated Cutaneous Neurofibromas (cNFs)
Enrolling by invitation·MMassachusetts General Hospital·Phase 1·NCT06300502·15 enrolled
Phase I Photodynamic Therapy (PDT) for Benign Dermal Neurofibromas (NF1)
Completed·HHarry T Whelan, MD·Phase 1·NCT01682811·20 enrolled
DPCP to Treat Cutaneous Neurofibromas Associated With NF1
Completed·—·Phase 1·NCT05438290·17 enrolled
Medical Treatment of "High-Risk" Neurofibromas
Completed·CCorewell Health West·Phase 2·NCT00846430·9 enrolled
Use of Topical Liquid Diclofenac Following Laser Microporation of Cutaneous Neurofibromas in Patients With NF1
Completed·FFundação Educacional Serra dos Órgãos·Phase 2·NCT03090971·7 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)